ImmPort, toward repurposing of open access immunological assay data for translational and clinical research

Immunology researchers are beginning to explore the possibilities of reproducibility, reuse and secondary analyses of immunology data. Open-access datasets are being applied in the validation of the methods used in the original studies, leveraging studies for meta-analysis, or generating new hypotheses. To promote these goals, the ImmPort data repository was created for the broader research community to explore the wide spectrum of clinical and basic research data and associated findings. The ImmPort ecosystem consists of four components–Private Data, Shared Data, Data Analysis, and Resources—for data archiving, dissemination, analyses, and reuse. To date, more than 300 studies have been made freely available through the Shared Data portal (www.immport.org/immport-open), which allows research data to be repurposed to accelerate the translation of new insights into discoveries.

[1]  Ryan D. Hernandez,et al.  Statistical inference of a convergent antibody repertoire response to influenza vaccine , 2015, Genome Medicine.

[2]  Hideaki Sugawara,et al.  The Sequence Read Archive , 2010, Nucleic Acids Res..

[3]  Sandra Romero-Steiner,et al.  Molecular signatures of antibody responses derived from a systems biology study of five human vaccines , 2022 .

[4]  John Chilton,et al.  The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update , 2016, Nucleic Acids Res..

[5]  Purvesh Khatri,et al.  Integrated, Multi-cohort Analysis Identifies Conserved Transcriptional Signatures across Multiple Respiratory Viruses , 2015, Immunity.

[6]  A. Butte,et al.  xCell: digitally portraying the tissue cellular heterogeneity landscape , 2017, Genome Biology.

[7]  Yu Lin,et al.  Ontology representation and analysis of vaccine formulation and administration and their effects on vaccine immune responses , 2012, Journal of Biomedical Semantics.

[8]  Harlan M Krumholz,et al.  Open Access Platforms for Sharing Clinical Trial Data. , 2016, JAMA.

[9]  Giulio Superti-Furga,et al.  Toward effective sharing of high-dimensional immunology data , 2014, Nature Biotechnology.

[10]  H E A L T H T R A C K I N G: F R O M T H E F I,et al.  The Politics Of The Health Insurance Portability And Accountability Act , 2001 .

[11]  Alexander D. Diehl,et al.  Logical Development of the Cell Ontology , 2011, BMC Bioinformatics.

[12]  N. Aghaeepour,et al.  Thinking outside the gate: single-cell assessments in multiple dimensions. , 2015, Immunity.

[13]  Jeffrey A. Wiser,et al.  ImmPort: disseminating data to the public for the future of immunology , 2014, Immunologic Research.

[14]  D M Fox,et al.  The politics of the Health Insurance Portability and Accountability Act. , 1997, Health affairs.

[15]  Atul J. Butte,et al.  Reanalysis of the Rituximab in ANCA-Associated Vasculitis trial identifies granulocyte subsets as a novel early marker of successful treatment , 2015, Arthritis Research & Therapy.

[16]  Jian Zhang,et al.  Protein Ontology: a controlled structured network of protein entities , 2013, Nucleic Acids Res..

[17]  Xing Qiu,et al.  High-Resolution Temporal Response Patterns to Influenza Vaccine Reveal a Distinct Human Plasma Cell Gene Signature , 2013, Scientific Reports.

[18]  Cristel G. Thomas,et al.  Meta-analysis of Cytometry Data Reveals Racial Differences in Immune Cells , 2017, bioRxiv.

[19]  S. Shen-Orr,et al.  Social network architecture of human immune cells unveiled by quantitative proteomics , 2017, Nature Immunology.

[20]  Steven B. Neuhauser,et al.  PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models. , 2017, Cancer research.

[21]  Kristian Thorlund,et al.  Reanalyses of randomized clinical trial data. , 2014, JAMA.

[22]  R. Scheuermann,et al.  Elucidation of seventeen human peripheral blood B‐cell subsets and quantification of the tetanus response using a density‐based method for the automated identification of cell populations in multidimensional flow cytometry data , 2010, Cytometry. Part B, Clinical cytometry.

[23]  Masato Kimura,et al.  NCBI’s Database of Genotypes and Phenotypes: dbGaP , 2013, Nucleic Acids Res..

[24]  Jian Zhang,et al.  Protein Ontology (PRO): enhancing and scaling up the representation of protein entities , 2016, Nucleic Acids Res..

[25]  Sandra Andorf,et al.  RImmPort: an R/Bioconductor package that enables ready‐for‐analysis immunology research data , 2017, Bioinform..

[26]  Piet Demeester,et al.  FlowSOM: Using self‐organizing maps for visualization and interpretation of cytometry data , 2015, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[27]  Sanchita Bhattacharya,et al.  The 10,000 Immunomes Project: Building a Resource for Human Immunology. , 2018, Cell reports.

[28]  Raphael Gottardo,et al.  Multicohort analysis reveals baseline transcriptional predictors of influenza vaccination responses , 2017, Science Immunology.

[29]  Patrick Dunn,et al.  The 10,000 Immunomes Project: A resource for human immunology , 2017, bioRxiv.